Clinical Trial Update: Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of oxaliplatin plus CPT-11 (irinotecan) for extensive-stage small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Swedish Medical Center | Conditions: Small Cell Lung Cancer | Phase 2 | Status: TERMINATED